An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Abroad (travel likely)RecruitingPHASE2

Conditions

Tobacco Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Missouri - Columbia, Columbia, Missouri, United States
Contact: Study coordinator (Brett Froeliger, PhD) · froeligerb@health.missouri.edu · 513-882-4785
Contact: Study coordinator (Madhura Athreya, MS) · athreyam@health.missouri.edu · 573-882-2977

Study leads

Brett Froeliger, PhD
Principal Investigator
University of Missouri-Columbia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

Smoking Cessation · Tobacco Use Disorder

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Tobacco Use Disorder

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Baltimore, United States

Overcoming Nicotine Dependence to Enable Quitting

Tobacco Use · Smoking Cessation · Smoking Behaviors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States

Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes

Tobacco Use Disorder

Abroad (travel likely)RecruitingPHASE2

Providence, United States · Burlington, United States